TrademarkOpen
Search / United States / 87303840

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

CSL

Registered
Section 8-Accepted
Used for: Antibodies for use in the treatment of infectious diseases, cancer and autoimmune diseases; drug delivery preparations…
Show more

Antibodies for use in the treatment of infectious diseases, cancer and autoimmune diseases; drug delivery preparations consisting of components that facilitate delivery of a wide range of pharmaceuticals and drugs to patients; excipients in the form of powders, capsules and liquids for delivery of drugs and pharmaceuticals to patients; and immunomodulators in the form of powders, capsules and liquids for alteration of immune response in humans

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 20 Jan 2017
    Application filed
    New Application Entered
  2. 12 Apr 2017
    Assigned to an examining attorney
    Assigned To Examiner
  3. 12 Apr 2017
    Office action issued
    Non-Final Action Written
  4. 11 Oct 2017
    Response to office action filed
    Teas Response To Office Action Received
  5. 20 Nov 2017
    Approved for publication
    Approved For Pub - Principal Register
  6. 26 Dec 2017
    Published for opposition
    Published For Opposition
  7. 20 Feb 2018
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  8. 9 Oct 2018
    Registered on the Principal Register
    Registered-Principal Register
All 40 events
2026-01-08Post Registration Action Mailed No Response Required
2026-01-088.ok
2026-01-08Nas8
2025-12-23Teas Response To Office Action-Post Reg Received
2025-12-22Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2025-12-22Attorney/Dom.rep.revoked And/Or Appointed
2025-12-22Teas Change Of Correspondence Received
2025-07-10Pra8
2025-06-26Case Assigned To Post Registration Paralegal
2025-03-20Es8r
2023-10-09Rem1
2022-10-11Teas Change Of Owner Address Received
2022-10-11Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2022-10-11Attorney/Dom.rep.revoked And/Or Appointed
2022-10-11Teas Change Of Domestic Representatives Address
2022-10-11Teas Change Of Correspondence Received
2022-10-11Applicant/Correspondence Changes (Non-Responsive) Entered
2018-12-17Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2018-12-17Attorney/Dom.rep.revoked And/Or Appointed
2018-10-09Registered-Principal Register
2018-09-06Case Assigned To Intent To Use Paralegal
2018-09-061(B) Basis Deleted; Proceed To Registration
2018-07-31Teas Delete 1(B) Basis Received
2018-07-31Notice Of Allowance Cancelled
2018-02-20Noa Mailed - Sou Required From Applicant
2017-12-26Published For Opposition
2017-12-26Official Gazette Publication Confirmation E-Mailed
2017-12-06Notification Of Notice Of Publication E-Mailed
2017-11-21Law Office Publication Review Completed
2017-11-20Approved For Pub - Principal Register
2017-10-30Correspondence Received In Law Office
2017-10-30Teas/Email Correspondence Entered
2017-10-25Assigned To Lie
2017-10-11Teas Response To Office Action Received
2017-04-12Assigned To Examiner
2017-04-12Non-Final Action Written
2017-04-12Non-Final Action E-Mailed
2017-04-12Notification Of Non-Final Action E-Mailed
2017-01-24New Application Office Supplied Data Entered
2017-01-20New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Antibodies for use in the treatment of infectious diseases, cancer and autoimmune diseases; drug delivery preparations consisting of components that facilitate delivery of a wide range of pharmaceuticals and drugs to patients; excipients in the form of powders, capsules and liquids for delivery of drugs and pharmaceuticals to patients; and immunomodulators in the form of powders, capsules and liquids for alteration of immune response in humans

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 9 Jan 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.